When was Elio founded?

Elio was founded in 2022 and raised its 1st funding round 4 years after it was founded.

Where is Elio located?

Elio is headquartered in San Mateo, United States.

How many employees does Elio have?

As of Sep 30, 2026, the latest employee count at Elio is 21.

Is Elio a funded company?

Elio is a funded company, having raised a total of $***** in its 1st and only funding round, a Series A round on Jul 23, 2026.

When was the latest funding round of Elio?

Elio's latest funding was a $***** Series A round on Jul 23, 2026, with participation from 6 investors. Its primary sector is Life Sciences Tech. In United States, the Life Sciences Tech sector has seen $3.88B in funding in 2026 to date.

Where does Elio rank among its competitors?

Elio ranks 9th amongst 57 active competitors, of which 12 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was Elio, which secured $21M in Jul, 2026.

Who are the top competitors of Elio?

Elio's top competitors include Median Technologies, Quibim and Modicus Prime. Among them, Elio secured the most recent funding round in July, 2026.

Elio - 2026 Company Profile, Funding & Competitors

Elio is a series A company based in San Mateo (United States), founded in 2022. It operates as a They revolutionize drug development with advanced optical AI. Elio has raised $21M in funding from Innovation Endeavors and Xora Innovation. The company has 57 active competitors, including 12 funded and 5 that have exited. Its top competitors include companies like Median Technologies, Quibim and Modicus Prime.

Company Details

They revolutionize drug development with advanced optical AI. They reinvent optical sensing to enhance biosensing capabilities, improving clinical trial success by better predicting drug safety and efficacy. Their intelligent optical filters offer new insights through direct, unbiased phenotyping from multiple modalities. The company's dynamic optical system integrates imaging, spectroscopy, and holographic interferometry into a single instrument, providing direct sample-to-answer analysis and streamlining processes. This technology allows access to the full spectrum of biological data without compromising sample integrity.

Website: www.eliolabs.com/
Email ID: *****@eliolabs.com

Key Metrics

Founded Year

2022

Location

San Mateo, United States

Stage

Series A

Total Funding

$21M in 1 round

Latest Funding Round

Series A, Jul 23, 2026, $*****

Investors

Innovation Endeavors & 5 more

Ranked

9^th among 57 active competitors

Employee Count

21 as on Sep 30, 2026

Similar Companies

Median Technologies & 70 more

View Elio's full profile

Elio has raised a total funding of $21M over 1 round. Its latest funding round was a Series A round on Jul 23, 2026 for $*****. 6 investors participated in its latest round. Elio has 5 institutional investors and 1 angel investor.

Here is the list of recent funding rounds of Elio:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jul 23, 2026	9582683	Series A	8384285	3180446	7395132	8499637

Access funding benchmarks and valuations. Sign up today!

View details of Elio's funding rounds and investors

Elio's employee count trend

Elio has 21 employees as of Sep 26. Here is Elio's employee count trend over the years:

Uncover Elio's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Elio include Median Technologies, Quibim and Modicus Prime. Here is the list of Top 10 competitors of Elio, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Median Technologies 2002, Valbonne (France), Public	Developer of medical imaging software for clinical trials and diagnostics	$5.28M	Matignon Finances, Lion Point Life Science Partners ... & 13 others	61/100
2nd	Quibim 2015, Valencia (Spain), Series A	Developer of medical imaging software for radiomics and biomarker analysis	$60M	Asabys Partners, Adara & 20 others	59/100
3rd	Modicus Prime 2020, La Porte (United States), Seed	Provider of an AI-based decision-making tool for healthcare professionals	$8M	Frist Cressey Ventures, Silverton Partners ... & 7 others	56/100
4th	VirtualScopics 2000, Rochester (United States), Acquired	Provider of imaging-based clinical trial solutions	$3.8M	Ravensbridge Capital, Trillium Group & 3 others	51/100
5th	IAG 2007, London (United Kingdom), Funding Raised	Imaging clinical research platform providing drug safety & efficacy in early phase trials	-	RBV Capital, Biovision Ventures	49/100
6th	FDNA 2010, Herzliya (Israel), Funding Raised	Developer of neurogenetic search and reference solution for the detection of facial dysmorphic features	-	Nacre Capital, Clal Biotechnology Industries	47/100
7th	XNAT 2012, Louisiana (United States), Unfunded	Open source imaging informatics software	-	-	43/100
8th	Ovizio 2009, Brussels (Belgium), Series A	Developer of an imaging system for microscopes	$9.34M	New Science Ventures, EIC Fund & 6 others	41/100
9th	Elio 2022, San Mateo (United States), Series A	They revolutionize drug development with advanced optical AI	$21M	Scribble Ventures, Innovation Endeavors & 4 others	38/100
10th	Bifrost 2021, Cambridge (United States), Funding Raised	Provider of optical pooled screening and analysis solutions for drug discovery	-	Black Opal Ventures	38/100